Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Scopus BioPharma Inc. (SCPS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.9900-0.0600 (-1.48%)
At close: 4:00PM EDT
3.9400 -0.05 (-1.25%)
After hours: 07:12PM EDT
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders

    NEW YORK, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, today announced that, on October 8, 2021, its 2021 Annual Meeting of Stockholders (the “Annual Meeting”) was adjourned to 1:00 p.m., Eastern time, on Friday, November 5, 2021, without any business being conducted, pursuant to a Stipulation and Court Order approved by the De

  • GlobeNewswire

    Scopus BioPharma to Present at the LD Micro Main Event

    Scopus to present on the recent launch of Duet Therapeutics, its wholly-owned subsidiary focused on immuno-oncology Presentation to include a discussion of preclinical data released at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society NEW YORK, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, today announced it wi

  • GlobeNewswire

    Scopus BioPharma Retaining Counsel to Investigate Unusual Market Activity

    NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company, announced today that it is retaining Boies Schiller Flexner LLP to conduct a market manipulation investigation. In the past several weeks, the shares of Scopus BioPharma have come under attack by abusive short sellers. During this period, the short volume ratio has reached nearly 70% and over 25% of the company’s market capitalization has been wiped out. The downward pr

Advertisement
Advertisement